Comprehensive efforts to increase adherence to statin therapy-Reference-Cited by-同舟云学术

Comprehensive efforts to increase adherence to statin therapy

Published:2017-01-10 Issue: Volume: Page:ehw628
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Vonbank Alexander,Agewall Stefan,Kjeldsen Keld Per,Lewis Basil S.,Torp-Pedersen Christian,Ceconi Claudio,Funck-Brentano Christian,Kaski Juan Carlos,Niessner Alexander,Tamargo Juan,Walther Thomas,Wassmann Sven,Rosano Giuseppe,Schmidt Harald,Saely Christoph H.,Drexel Heinz

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Reference78 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

3. Yusuf S Lonn E Pais P Bosch J Lopez-Jaramillo P Zhu J Xavier D Avezum A Leiter LA Piegas LS Parkhomenko A Keltai M Keltai K Sliwa K Chazova I Peters RJ Held C Yusoff K Lewis BS Jansky P Khunti K Toff WD Reid CM Varigos J Accini JL McKelvie R Pogue J Jung H Liu L Diaz R Dans A Dagenais G. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 2016;374:2032–2043.

4. Catapano AL Graham I De BG Wiklund O Chapman MJ Drexel H Hoes AW Jennings CS Landmesser U Pedersen TR Reiner Z Riccardi G Taskinen MR Tokgozoglu L Verschuren WM Vlachopoulos C Wood DA Zamorano JL. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2999–3058.

5. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective;Current Medical Research and Opinion;2024-09-09

2. Utilising survey data and qualitative information to inform a logic model to support older people in custody with common mental and physical health problems: Addressing the physical and mental health needs of older prisoners (the PAMHOP study);International Journal of Law and Psychiatry;2024-07

3. Early Management of Blood Lipid Levels with Non-Statin Lipid-Lowering Drugs in Acute Coronary Syndrome: A Mini Review;Cardiovascular Drugs and Therapy;2024-06-29

4. Metformin-induced PCSK9 inhibition further decreases LDL-C following statin treatment in patients with coronary artery disease and without diabetes;Journal of Cardiovascular Pharmacology;2024-05-21

5. Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk;Clinical Chemistry;2024-03